
---
title: '突发，热门千亿龙头一季度亏37亿。奥密克戎灭活疫苗迈入临床试验，北上资金重点看好4股'
categories: 
 - 金融
 - 证券时报网
 - 数据
headimg: 'https://data.stcn.com/djsj/202204/W020220427290176522873.jpeg'
author: 证券时报网
comments: false
date: Wed, 27 Apr 2022 08:02:00 GMT
thumbnail: 'https://data.stcn.com/djsj/202204/W020220427290176522873.jpeg'
---

<div>   
<p>多只猪概念股一季度亏损，业绩同比下滑，股价却抗跌。</p><p>4月26日盘后，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300498" code="300498">温氏股份</a>披露第一季度报告，报告期内，公司实现营业收入145.86亿元，同比减少13.26%；净利润亏损37.63亿元，同比下降792.39%。对于一季度的亏损，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300498" code="300498">温氏股份</a>公告称，原因是“养猪业经营亏损”。此外，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300498" code="300498">温氏股份</a>一季度资产减值损失高达9.97亿元，为计提肉猪存货跌价准备。</p><p>从<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300498" code="300498">温氏股份</a>的年报数据来看，2021年公司营业收入为649.54亿元，同比下降13.31%；净亏损134.04亿元，与2020年同期净利润74.26亿元相比，由盈转亏。<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300498" code="300498">温氏股份</a>称，饲料持续上涨，毛猪销售均价同比下降48.18%，使公司肉猪养殖业务利润同比大幅下降。</p><p style="text-align:center"><img data-galleryid data-ratio="1.2871794871794873" data-s="300,640" src="https://data.stcn.com/djsj/202204/W020220427290176522873.jpeg" data-type="jpeg" data-w="1170" data-imgqrcoded="1" width="500px" height="643.5185185185185px" style="width: 500px; height: 643.5185185185185px;" oldsrc="W020220427290176522873.jpeg" referrerpolicy="no-referrer"></p><p>从目前已经披露一季报或业绩预告的8家猪概念股来看，仅<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000895" code="000895">双汇发展</a>和<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002330" code="002330">得利斯</a>的一季度业绩实现盈利且同比增长，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000860" code="000860">顺鑫农业</a>预计一季度净利润约9000万元-1.18亿元，同比下降68.38%-75.88%。<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000735" code="000735">罗牛山</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002840" code="002840">华统股份</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002458" code="002458">益生股份</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300498" code="300498">温氏股份</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002548" code="002548">金新农</a>的一季度业绩同比下降幅度均超100%。</p><p style="text-align:center"><img data-galleryid data-ratio="0.3522975929978118" data-s="300,640" src="https://data.stcn.com/djsj/202204/W020220427290177653993.png" data-type="png" data-w="914" data-imgqrcoded="1" width="500px" height="176.1487964989059px" style="width: 500px; height: 176.1487964989059px;" oldsrc="W020220427290177653993.png" referrerpolicy="no-referrer"></p><p>虽然业绩大幅下滑，股价却抗跌。今年以来，猪概念股的股价表现比较抗跌，超七成股价跑赢大盘，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600975" code="600975">新五丰</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603363" code="603363">傲农生物</a>年内分别上涨54.34%和29.21%，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300498" code="300498">温氏股份</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603477" code="603477">巨星农牧</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002124" code="002124">天邦股份</a>等股的股价年内累计录得正值，大幅度跑赢大盘。</p><p>机构对于猪概念股的后市情况多偏向乐观。据农业农村部消息，截至4月中旬，全国生猪价格已经连续3周小幅回升，结束了16周连续下跌的趋势，南方多地猪价正在从6元时代迈入8元时代。<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000776" code="000776">广发证券</a>认为，猪价反弹减轻亏损幅度，近期受需求复苏、屠宰企业囤货等因素影响，全国猪价快速上行，仔猪和种猪价格反弹较为明显，行业补栏情绪提升明显。短期猪价上涨过快，面临一定调整压力，后续猪价或逐步震荡上行，周期反转仍需等待。</p><p><strong>两款奥密克戎灭活新冠疫苗获批临床试验</strong></p><p><strong>北上资金重点看好4股</strong></p><p>据中国生物官微消息，国药集团中国生物北京生物制品研究所奥密克戎变异株新冠病毒灭活疫苗获得了中国国家药监局颁发的临床批件。这意味着，国药集团中国生物的奥株灭活疫苗即将进入临床试验阶段，成为全球最早获批进入临床的奥密克戎株灭活疫苗。中国生物将采用随机、双盲、队列研究的形式，在已完成2或3剂新冠疫苗接种的18岁及以上人群中进行序贯免疫临床研究，评价奥密克戎变异株新冠病毒灭活疫苗的安全性和免疫原性。</p><p>与此同时，北京科兴生物制品有限公司官微发布消息称，国家药监局正式批准科兴控股生物技术有限公司（简称“科兴”）基于奥密克戎变异株（Omicron）研制的新冠病毒灭活疫苗进入临床研究，用以评价新冠病毒变异株疫苗在各类人群中的安全性和免疫原性。</p><p>受此消息影响，昨日在大盘下挫的背景下，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600511" code="600511">国药股份</a>午后迅速拉升封上涨停板，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000028" code="000028">国药一致</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600420" code="600420">国药现代</a>跟涨。</p><p>证券时报·数据宝统计，A股布局新冠疫苗的概念股股价4月以来平均下跌20.28%，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS688185" code="688185">康希诺</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300601" code="300601">康泰生物</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600211" code="600211">西藏药业</a>等5股的股价月内跌幅均超30%。按照最新股价较去年以来的高点来看，新冠疫苗概念股的股价已经较去年高点平均回调超50%，其中<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS688185" code="688185">康希诺</a>的回调幅度最大，公司股价从去年6月的高点798元/股一路震荡下行，累计跌幅达81.18%。不过根据公司披露的2021年年报显示，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS688185" code="688185">康希诺</a>去年全年实现营业收入约43亿元，同比增长17174.82%，归属于上市公司股东的净利润19.14亿元，同比增长582.65%，成功实现扭亏。由于首次实现盈利，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS688185" code="688185">康希诺</a>成为科创板首个成功“摘U”的生物科技公司。</p><p style="text-align:center"><img data-galleryid data-ratio="0.5178997613365155" data-s="300,640" src="https://data.stcn.com/djsj/202204/W020220427290178284596.png" data-type="png" data-w="838" data-imgqrcoded="1" width="500px" height="258.9498806682577px" style="width: 500px; height: 258.9498806682577px;" oldsrc="W020220427290178284596.png" referrerpolicy="no-referrer"></p><p>目前，已有8只新冠疫苗概念股发布了今年第一季度业绩报告或业绩预告，按照报告数据或预告下限数据来看，全部实现盈利。<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300122" code="300122">智飞生物</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603392" code="603392">万泰生物</a>的一季度归母净利润额均超过10亿元，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300601" code="300601">康泰生物</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603392" code="603392">万泰生物</a>的一季度归母净利润同比翻倍增长，分别增长893.93%和360.18%。</p><p>北上资金近期看好新冠疫苗概念股，上周以来，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603392" code="603392">万泰生物</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300122" code="300122">智飞生物</a>分别获得9.79亿元和4.34亿元北上资金净买入，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300601" code="300601">康泰生物</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000963" code="000963">华东医药</a>的北上资金净买入额均超亿元。（数据宝 郭洁）</p><p style="text-align: center;"><img data-galleryid data-ratio="0.37295690936106984" data-s="300,640" src="https://data.stcn.com/djsj/202204/W020220427290178808753.png" data-type="png" data-w="673" data-imgqrcoded="1" width="500px" height="186.47845468053492px" style="width: 500px; height: 186.47845468053492px;" oldsrc="W020220427290178808753.png" referrerpolicy="no-referrer"></p>
  
</div>
            